-
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
10 May 2024 06:51 GMT
… a combination therapy of cisplatin and etoposide, a classic … year. Following small cell lung cancer and pancreatic cancer, attempts … to be effective in lung cancer, pancreatic cancer, and … -designation-for-small-cell-lung-cancer-302142057.html
SOURCE SN …
-
Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma
13 May 2024 11:01 GMT
… and pembrolizumab coformulation in lung cancer, which are routinely monitored … in combination with platinum (cisplatin or carboplatin) and FU … S.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
13 May 2024 11:00 GMT
… developed for radiation-induced and cisplatin-related toxicities. The FDA has … patients with non-small cell lung cancer and locally advanced pancreatic cancer …
-
Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer
29 Apr 2024 13:13 GMT
… and targeted treatments for lung cancer by harnessing the … biological bombs for efficient lung cancer therapy. J Colloid … al. Establishment of acquired cisplatin resistance in ovarian cancer … KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and …
-
MCM5 is a Novel Therapeutic Target for Glioblastoma
13 May 2024 08:47 GMT
… of DNA damage caused by cisplatin.21 However, thus far, … indicating its role in cisplatin resistance in head and … upregulated by VN1R5 promotes cisplatin resistance in head and … HDAC1-Mediated Malignant Progression of Lung Cancer. Front Cell Develop Biol. …
-
Tislelizumab Earns European Approval in Non–Small Cell Lung Cancer
23 Apr 2024 17:43 GMT
… tislelizumab plus carboplatin or cisplatin and pemetrexed produced a … treatment for non-small cell lung cancer. News release. BeiGene, … squamous non–small-cell lung cancer: a phase 3 randomized … treatment for non-small cell lung cancer. News release. BeiGene, …
-
Research Progress of Baihe Gujin Decoction in the Treatment of Lung Cancer
23 Apr 2024 17:30 GMT
… Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the … Lung Cancers
Clinical Study of Baihe Gujin Decoction in the Treatment of Lung Cancer … of lung cancer patients. For instance, Baihe Gujin decoction with vinorelbine/cisplatin …
-
EMA Committee recommends nod for Bristol Myers Squibb Opdivo in combination with Cisplatin, Gemcitabine for Urothelial Carcinoma
28 Apr 2024 07:55 GMT
… nivolumab) in combination with cisplatin and gemcitabine for the … in combination with cisplatin and gemcitabine followed by … in combination with cisplatin and gemcitabine had … carcinoma, non-small cell lung cancer, malignant pleural mesothelioma, melanoma …
-
Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens
11 Apr 2024 16:52 GMT
… for non-small-cell lung cancer (NSCLC) patients ineligible … ,7,8 of all lung cancers cases, with nearly 60% … small-cell lung cancer: a cost-effectiveness analysis. Translational Lung Cancer Res. … -utility analysis of gemcitabine, cisplatin, and S-1 as …
-
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
26 Apr 2024 11:14 GMT
… carcinoma, non-small cell lung cancer, malignant pleural mesothelioma, … positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, … ) in combination with cisplatin and gemcitabine may not …